Table 1.
ZFNs | TALENs | CRISPR/Cas9 | RFNs | |
---|---|---|---|---|
Cost | +++++ | +++ | ++ | ++ |
Reagent design limitations | +++ | + | ++ | +++ |
Reagent development difficulty | +++ | +++ | + | ++ |
Efficiency | +++ | ++++ | ++++ | +++ |
Off-target effects | ++ | ++ | +++++ | + |
Abbreviations: ZFNs, Zinc-Finger Nucleases; TALENs, Transcription Activator-Like Effector Nucleases; CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats; RFNs, dimeric CRISPR RNA-guided FokI nucleases.